Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Indacaterol/glycopyrronium in symptomatic patients with COPD (GOLD B and GOLD D) versus salmeterol/fluticasone: ILLUMINATE/LANTERN pooled analysis

Claus Vogelmeier,1 Nanshan Zhong,2 Michael J Humphries,3 Karen Mezzi,4 Robert Fogel,5 Giovanni Bader,4 Francesco Patalano,4 Donald Banerji5 1Department of Medicine, Pulmonary and Critical Care Medicine, University Medical Center Giessen and Marburg, Philipps-University Marburg, Member of the German...

Full description

Bibliographic Details
Main Authors: Vogelmeier C, Zhong NS, Humphries MJ, Mezzi K, Fogel R, Bader G, Patalano F, Banerji D
Format: Article
Language:English
Published: Dove Medical Press 2016-12-01
Series:International Journal of COPD
Subjects:
COPD
exacerbation
LABA/LAMA
LABA/ICS
lung function
Online Access:https://www.dovepress.com/indacaterolglycopyrronium-in-symptomatic-patients-with-copd-gold-b-and-peer-reviewed-article-COPD

Internet

https://www.dovepress.com/indacaterolglycopyrronium-in-symptomatic-patients-with-copd-gold-b-and-peer-reviewed-article-COPD

Similar Items